Cytodyn Inc (CYDY)

[Saltz]

In my very strong opinion:

Combo Trial will completely enroll within a week of Q2 2017. PE data will be out four weeks later. Data will be clean.

P3 Mono will fully enroll all 300 patients prior to the end of the year.

GVHD in play for partnership and/or licensing deal later this year possibly sooner.

Bottom line is this is going to heat up in a big way the second half of this year.

Ask yourself...do you think the data will be strong?

Completing enrollment has been the biggest set back with CYDY. That set back is on the verge of being history.

Mark this post and ignore the naysayer(s).